| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |